SHC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
321.4M
+14.8%
280.0M
-7.7%
303.4M
-2.5%
311.3M
+5.8%
294.3M
Cost of Revenue
143.4M
+7.8%
133.0M
-3.3%
137.5M
+2.8%
133.8M
+4.7%
127.7M
Gross Profit
178.0M
+21.0%
147.1M
-11.4%
165.9M
-6.6%
177.6M
+6.6%
166.6M
Operating Expenses
71.2M
-0.1%
71.2M
+1716.9%
-4406000
-106.6%
66.4M
-40.8%
112.2M
R&D
0
0
0
0
0
SG&A
68.2M
-0.1%
68.2M
+18.6%
57.5M
-9.1%
63.3M
-8.1%
68.9M
Operating Income
106.8M
+40.8%
75.8M
-55.5%
170.3M
+53.2%
111.2M
+104.3%
54.4M
EBITDA
140.2M
+31.5%
106.6M
-22.7%
137.9M
-1.2%
139.5M
+13.0%
123.4M
Net Income
53.6M
+101.7%
26.6M
-23.7%
34.8M
-28.0%
48.4M
+507.9%
8.0M
EPS (Basic)
$0.19
+111.1%
$0.09
-25.0%
$0.12
-29.4%
$0.17
+466.7%
$0.03
EPS (Diluted)
$0.19
+111.1%
$0.09
-25.0%
$0.12
-29.4%
$0.17
+466.7%
$0.03
Shares (Diluted)
288.1M
+0.2%
287.6M
-0.7%
289.6M
+1.0%
286.7M
+0.3%
285.8M
Sotera Health (SHC) โ€” Financials